2018
DOI: 10.18632/aging.101531
|View full text |Cite
|
Sign up to set email alerts
|

Integrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma

Abstract: Despite the rapid growing and aging of populations worldwide, our knowledge on hepatocellular carcinoma (HCC) is still age-standardized rather than age-specific, with only few studies exploring the topic from a genetic point of view. Here, we analyze clinical and genetic aspects of HCC in patients of different age groups with the major attention directed to children (≤20 y) and elderly groups (≥80 y). A number of significant differences were found in elderly patients compared to children group, including small… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 58 publications
(103 reference statements)
0
7
0
Order By: Relevance
“…In that work, the authors also showed that AKR1B10 knockdown in vitro corresponded with increased apoptotic cell death, decreased colony formation and size, and improved response to doxorubicin. In an analysis involving children and older adults (≥80 years), AKR1B10 protein levels differed between HCC tissues and near-tumor tissues for HCC patients [27]. Interestingly, this study also revealed a significant difference in AKR1B10 expression according to age, with increased expression in older patients compared to levels in patients younger than 40 years.…”
Section: Akr1b10 and Hccmentioning
confidence: 67%
“…In that work, the authors also showed that AKR1B10 knockdown in vitro corresponded with increased apoptotic cell death, decreased colony formation and size, and improved response to doxorubicin. In an analysis involving children and older adults (≥80 years), AKR1B10 protein levels differed between HCC tissues and near-tumor tissues for HCC patients [27]. Interestingly, this study also revealed a significant difference in AKR1B10 expression according to age, with increased expression in older patients compared to levels in patients younger than 40 years.…”
Section: Akr1b10 and Hccmentioning
confidence: 67%
“…Aging is associated with impaired immunological function and an accumulated chronic inflammatory microenvironment, which might facilitate tumor formation and progression (Kuilman et al, 2008 ). Recently, a retrospective study found that elderly patients exhibited better biological characteristics than children, but the underlying mechanisms for this observation remain unknown (Atyah et al, 2018 ). AKR1B10, which plays an important role in the adoptive response to oxidative stress and damage and is considered to be involved in leading theories of aging, was identified as a crucial gene in the increase of carcinogenesis with age (Schmitz et al, 2011 ; Sato et al, 2016 ).…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, a latest retrospective study of 131 HCC patients (98 elderly patients and 33 children) reported that patients aged >85 years had smaller tumors compared with children, and that their survival rate was 92.4%, which was comparable with that of patients aged ≤ 85 years and was significantly higher than that of the children (Atyah et al, 2018 ). AKR1B10, which is involved in leading theories on aging, has also been identified as a crucial gene in the increase of carcinogenesis with age (Matkowskyj et al, 2014 ; Atyah et al, 2018 ). However, to our best knowledge, the role of the aging process in HCC remains unclear, and the correlation between aging genes and HCC prognosis has not yet been systematically evaluated.…”
Section: Introductionmentioning
confidence: 95%
“…[14] Puccini, et al showed a signi cantly different mutation rates between younger and older patients in colorectal cancer. [15] Atyah, et al also observed differencesin gene mutations, copy number variants, and mRNA expressions in older and younger patients with hepatocellular carcinoma [14]. However, further studies are still needed to illustrate the mechanisms behind the phenomena observed in this study.…”
mentioning
confidence: 66%